Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | PAM | P19021 | 2/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862614 | 0.98 | DGKA (0.57) | DGKADNM1PAOXEPHX2PAM | |
| SCHEMBL16330783 | 0.94 | DGKA (0.52) | DGKADNM1PAOXEPHX2PAM | |
| SCHEMBL17525969 | 0.90 | EPHX2 (0.50) | DGKADNM1PAOXEPHX2PAM | |
| SCHEMBL14174579 | 0.90 | DGKA (0.50) | DGKADNM1PAOXEPHX2PAM | |
| SCHEMBL14016564 | 0.86 | DGKA (0.59) | DGKADNM1PAOXPAMPRSS1 | |
| SCHEMBL14879118 | 0.85 | ADRA2A (0.48) | DGKADNM1EPHX2TSHRMAPT | |
| SCHEMBL16020410 | 0.85 | ADRA2A (0.48) | DGKADNM1EPHX2TSHRMAPT | |
| SCHEMBL4570263 | 0.85 | ADRA2A (0.48) | DGKADNM1EPHX2TSHRMAPT | |
| SCHEMBL16020457 | 0.85 | ADRA2A (0.48) | DGKADNM1EPHX2TSHRMAPT | |
| SCHEMBL23631741 | 0.83 | DGKA (0.88) | DGKADNM1EPHX2PAMPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180042996-A1 | Hydrogel-Linked IL-1ra Prodrug | ASCENDIS PHARMA OSTEOARTHRITIS DIVISION A/S (DK) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180042996-A1 | Hydrogel-Linked IL-1ra Prodrug | IL1A, IL1B, IL1R1 | DGKA 2415/4885DNM1 4767/4885PAOX 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.